在五种类型的溶液中稀释的常见血管活性药物的稳定性研究
Han Yang1, Bingbing Xiang1, Deiying Gong2
1Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in pharmacology
|October 6, 2025
概括
使用常见的静脉注射溶液评估了血管活性药物的稳定性. 大多数药物在室温下保持稳定8小时,这表明未推稀释的安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 制药化学 制药化学 制药化学
- 临床药房 临床药房
背景情况:
- 血管活性药物在术后护理中至关重要.
- 标准稀释协议存在,但有时使用非推的溶液.
- 血管活性药物在非推溶液中的稳定性尚不清楚.
研究的目的:
- 评估常用的血管活性药物的稳定性.
- 在五种经常使用的静脉注射溶液中稀释时评估稳定性.
- 为了确定药物的稳定性在室温下没有光保护8小时.
主要方法:
- 血管活性药物被稀释在0.9%的化,乳酸林格,糖盐水,5%的糖和10%的糖溶液中.
- 样品在24°C±1°C的温度下保存,没有光保护.
- 外观,pH值和药物含量 (通过HPLC) 在0,2,4,6和8小时后进行测量.
主要成果:
- 所有的解决方案保持清晰和透明8小时.
- 大多数药物在8小时内没有显著的含量变化,除了异二醇化物.
- 对于阿米奥达龙,尼卡迪平,普罗帕芬和迪尔提阿泽姆化物,观察到显著的pH值变化.
结论:
- 通常使用的血管活性药物在室温下在没有光线的情况下在五种常见溶液中稀释时,通常保持稳定的性能8小时.
- 虽然药物含量基本上不受影响,但某些药物的pH稳定性有所不同,在临床实践中需要考虑.
相关概念视频
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
235
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
235
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
178
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
178
Steady State Concentration
5.8K
A steady state refers to the level of a drug in the body once it has reached an equilibrium between administration and elimination. It represents the point at which the drug administration rate equals the drug elimination rate, resulting in a relatively constant concentration in the body over time. The dynamic equilibrium is crucial to ensure the drug's effectiveness with minimal risk of toxicity.
Most drugs are administered in repeated doses at fixed intervals or through continuous...
Most drugs are administered in repeated doses at fixed intervals or through continuous...
5.8K
In Vitro Drug Dissolution: Compendial Testing Models I
227
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
227
In Vitro Drug Dissolution: Alternative Methods
194
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
194
In Vitro Drug Dissolution: Compendial Testing Models II
245
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
245


